Gadd45β expression in chondrosarcoma: A pilot study for diagnostic and biological implications in histological grading

Diagnostic Pathology

Volumn 5, Issue 1, 2010, Pages

  Zenmyo, Michihisa ^a   Tanimoto, Akihide ^a   Sakakima, Harutoshi ^b   Yokouchi, Masahiro ^a   Nagano, Satoshi ^a   Yamamoto, Takuya ^a   Ishido, Yasuhiro ^a   Komiya, Setsuro ^a   Ijiri, Kosei ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIATION ANTIGEN; GADD45B PROTEIN, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BONE TUMOR; CANCER STAGING; CELL DIFFERENTIATION; CHEMISTRY; CHONDROMA; CHONDROSARCOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; MIDDLE AGED; PATHOLOGY; PILOT STUDY; PREDICTIVE VALUE; PROGNOSIS;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGENS, DIFFERENTIATION; BONE NEOPLASMS; CELL DIFFERENTIATION; CHONDROMA; CHONDROSARCOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77957723508     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-5-69     Document Type: Article

References (20)

1. Larsson SE, Lorentzon R. The incidence of malignant primary bone tumours in relation to age, sex and site. A study of osteogenic sarcoma, chondrosarcoma, and Ewing's sarcoma diagnosed in Sweden from 1958 to 1968. J Bone joint Surg Br 1974, 56:534-540.
2. Hartley AL, Blair V, Harris M, Birch JM, Banerjee SS, Freemont AJ, McClure J, McWilliam LJ. Sarcomas in north west England:II. Incidence. Br J Cancer 1991, 64:1145-1150. 1977876, 1662534.
3. Hiraoka K, Zenmyo M, Komiya S, Kawabata R, Yokouchi M, Suzuki R, Hamada T, Kato S, Nagata K. Relationship of p21(waf1/cip1) and differentiation on chondrosarcoma cells. Virchows Arch 2002, 440:285-290. 10.1007/s004280100495, 11889599.
4. Unni KK. General aspects and data on 11,087 cases. Dahlin's bone tumor 1996, 25. Lippincott-Raven, Minnesota, Fifth.
5. Bertoni HD, Czerniak B. Malignant cartilage tumor. Bone tumors 1998, 353-440. (Mo):Mosby, St Louis.
6. Endo M, Matsumura T, Yamaguchi T. Cyclooxygenase-2 overexpression associated with a poor prognosis in chondrosarcomas. Human pathology 2006, 37:471-476. 10.1016/j.humpath.2005.12.001, 16564923.
7. Alho A, Skjeldal S, Melvik JE, Pettersen EO, Larsen TE. The clinical importance of DNA synthesis and aneuploidy in bone and soft tissue tumours. Anticancer Res 1993, 13:2383-2387.
8. Kreicbergs A, Boquist L, Borssén B, Larsson SE. Prognostic factors in chondrosarcoma: a comparative study of cellular DNA content and clinicopathologic features. Cancer 1982, 50:577-583. 10.1002/1097-0142(19820801)50:3<577::AID-CNCR2820500332>3.0.CO;2-G, 7093898.
9. Alho A, Connor JF, Mankin HJ, Schiller AL, Campbell CJ. Assessment of malignancy of cartilage tumors using flow cytometry. A preliminary report. J Bone Joint Surg Am 1983, 65:779-785.
10. Dobashi Y, Sugimura H, Sato A, Hirabayashi T, Kanda H, Kitagawa T, Kawaguchi N, Imamura T, Machinami R. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma. Diagn Mol Pathol 1993, 2:257-263.
11. Nawa G, Ueda T, Mori S, Yoshikawa H, Fukuda H, Ishiguro S, Funai H, Uchida A. Prognostic significance of Ki67(MIB-1) proliferation index and p53 over-expression in chondrosarcomas. Int J Cancer 1996, 69:86-9. 10.1002/(SICI)1097-0215(19960422)69:2<86::AID-IJC3>3.0.CO;2-R, 8608988.
12. Urist MR. Bone: Formation by autoinduction. Science 1965, 150:893-899. 10.1126/science.150.3698.893, 5319761.
13. Goldring MB, Tsuchimochi K, Ijiri K. The control of chondrogenesis. J Cellular Biochem 2006, 97:33-44.
14. Ijiri K, Zerbini LF, Peng H, Correa RG, Lu B, Walsh N, Zhao Y, Taniguchi N, Huang XL, Otu H, Wang H, Wang JF, Komiya S, Ducy P, Rahman MU, Flavell RA, Gravallese EM, Oettgen P, Libermann TA, Goldring MB. A novel role for Gadd45b as a mediator of MMp-13 gene expression during chondrocyte terminal differentiation. J Biol Chem 2005, 280:38544-38554. 10.1074/jbc.M504202200, 16144844.
15. Bertoni F, Bacchini P, Hogendoorn PCW. Chondrosarcoma. World health Organization Classification of Tumours. Pathology and genetics of tumours of soft tissue and bone 2002, 247-251. IARC Press, Lyon, Fletcher CDM, Unni KK, Mertens F.
16. Murphey MD, Flemming DJ, Boyea SR, Bojescul JA, Sweet DE, Temple HT. Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics 1998, 18:1213-1237.
17. Skeletal lesions interobserver correlation among expert diagnosticians study group Reliability of histopathological and radiologic grading of cartilaginous neoplasms in long bones. J Bone joint Surg Am 2007, 89:2113-2123. 10.2106/JBJS.F.01530, 17908885, Skeletal lesions interobserver correlation among expert diagnosticians study group.
18. Amanullah A, Azam N, Balliet A, Hollander C, Hoffman B, Fornace A, Liebermann D. Cell signalling: cell survival and a Gadd45-factor deficiency. Nature 2003, 424:741-742. 10.1038/424741b, 12917673.
19. Selvakumaran M, Lin HK, Sjin RT, Reed JC, Liebermann DA, Hoffman B. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells. Mol Cell Biol 1994, 14:2352-2360. 358602, 8139540.
20. Tsuchimochi K, Otero M, Dragomir CL, Plumb DA, Zerbini LF, Libermann TA, Marcu KB, Komiya S, Ijiri K, Goldring MB. Gadd45beta enhances Col10a1 transcription via the MTK1/MKK3/6/p38 axis and activation of C/EBPbeta-TAD4 in terminally differentiating chondrocytes. J Biol Chem 2010, 285:8395-83407. 10.1074/jbc.M109.038638, 20048163.